Rodney Dawson

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study”.

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1

N/A

4.4DataRank · unranked

85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01196-20

N/A

1.3DataRank · unranked

26 citations

Mahmoud Tareq Abdelwahab, Bronwyn Hendricks, Nikhil Gupte, Kim Narunsky, Lubbe Wiesner +5 more

Myocardial Steatosis Among Antiretroviral Therapy–Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa245

N/A

0.788DataRank · unranked

22 citations

Kim‐Lien Nguyen, Vlad G. Zaha, Kara W Chew, R. L. Morrison, Ntobeko A. B. Ntusi +29 more

Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)

Clinical Infectious Diseases(2022)10.1093/cid/ciac707

N/A

0.726DataRank · unranked

13 citations

Patrick Phillips, Ekaterina V. Kurbatova, Andrew Vernon, Payam Nahid, Rodney Dawson +17 more

Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis

The Lancet Microbe(2021)10.1016/s2666-5247(21)00058-6

N/A

0.561DataRank · unranked

41 citations

Xiang Yu, Bronwyn Smith, Xin Liu, Jingcai Gao, Andreas H. Diacon +18 more

Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis

The Lancet HIV(2025)10.1016/s2352-3018(25)00043-8

N/A

0.398DataRank · unranked

6 citations

Carlos Malvestutto, Maya Watanabe, Emma Smith, Heather J. Ribaudo, Sara McCallum +90 more

Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention

Clinical Infectious Diseases(2024)10.1093/cid/ciae183

N/A

0.372DataRank · unranked

6 citations

Yoninah Cramer, Marjorie Z. Imperial, Susan L. Rosenkranz, Anchalee Avihingsanon, Roberto C. Arduino +7 more

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis

Clinical Infectious Diseases(2024)10.1093/cid/ciae119

N/A

0.306DataRank · unranked

6 citations

Ava Y Xu, Gustavo E. Velásquez, Nan Zhang, Vincent Chang, Ekaterina V. Kurbatova +16 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries

Clinical Infectious Diseases(2024)10.1093/cid/ciae269

N/A

0.241DataRank · unranked

4 citations

Cissy Kityo, Michael D. Hughes, Caitlyn McCarthy, Carole L. Wallis, Mina C. Hosseinipour +28 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis

Clinical Infectious Diseases(2023)10.1093/cid/ciad301

N/A

0DataRank · unranked

7 citations

Xingye Wu, Soyeon Kim, Katie McIntire, Linda Naini, Michael D. Hughes +21 more

PET/CT guided tuberculosis treatment shortening: a randomized trial

medRxiv(2024)10.1101/2024.10.03.24314723

N/A

0DataRank · unranked

10 citations

Ray Y. Chen, Xiang Yu, Bronwyn Smith, Xin Liu, Jingcai Gao +50 more

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis

Pharmacogenetics and Genomics(2025)10.1097/fpc.0000000000000562

N/A

0DataRank · unranked

3 citations

Anne F. Luetkemeyer, Marjorie Z. Imperial, Rodney Dawson, Yoninah Cramer, Sue Rosenkranz +10 more

Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf270

N/A

0DataRank · unranked

1 citations

Caitlyn McCarthy, Serena P. Koenig, Michael D Hughes, Carole L. Wallis, Isaac Tsikhutsu +41 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4

N/A

0DataRank · unranked

1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more

Clofazimine pharmacokinetics in patients with TB: dosing implications

Journal of Antimicrobial Chemotherapy(2020)10.1093/jac/dkaa310

N/A

0DataRank · unranked

70 citations

Sean Wasserman, James C.M. Brust, Neel R. Gandhi, Graeme Meintjes, Daniel E. Everitt +7 more